#1050 Small Patients, Big Battles: Caring for Children with Leukemia and Lymphoma (15 Credits/hours)

Course Details:
Launch Date: August 5, 2025
Expires: August 31, 2027

Course #1050
15 Credits/Hours

Course Overview

This comprehensive course examines the pathophysiology, diagnosis, and management of pediatric hematologic malignancies, with a focus on leukemias and lymphomas. Designed for healthcare professionals, medical students, and researchers, the course provides an in-depth exploration of cellular mechanisms, clinical presentations, and evidence-based treatment protocols for childhood blood cancers. Through examination of current research and clinical guidelines, participants will develop a thorough understanding of how these diseases affect pediatric patients and the multidisciplinary approaches required for optimal patient outcomes.

Table of Contents

1. Introduction to Pediatric Hematologic Malignancies
2. Acute Lymphoblastic Leukemia in Children
3. Acute Myeloid Leukemia in Pediatric Populations
4. Chronic Leukemias and Myeloproliferative Disorders
5. Hodgkin Lymphoma in Children and Adolescents
6. Non-Hodgkin Lymphomas in Pediatric Patients
7. Diagnostic Approaches and Laboratory Techniques
8. Treatment Modalities and Therapeutic Protocols
9. Supportive Care, Survivorship, and Long-Term Outcomes

Learning Objectives

Upon completion of this course, students will be able to:

• Differentiate between the major types of pediatric leukemias and lymphomas based on cellular origin, genetic markers, and clinical presentation.
• Analyze the pathophysiological mechanisms underlying malignant transformation in pediatric hematologic cells.
• Interpret diagnostic findings including complete blood counts, bone marrow aspirates, flow cytometry, and molecular genetic studies.
• Evaluate risk stratification systems used to guide treatment intensity in pediatric leukemia and lymphoma patients.
• Apply evidence-based treatment protocols including chemotherapy, targeted therapy, and immunotherapy approaches.
• Recognize the acute and long-term complications associated with treatment of pediatric blood cancers.
• Assess the psychosocial impact of hematologic malignancies on pediatric patients and their families.
• Implement supportive care measures to manage treatment-related toxicities and improve quality of life.
• Identify current research directions and emerging therapies in pediatric hematologic oncology.
• Collaborate effectively within multidisciplinary teams to provide comprehensive care for children with blood cancers.